(Q54592312)

English

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

1 reference

based on heuristic

inferred from title

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

5

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

1 June 2018

4

object named as

Susan O'Brien

1 reference

Europe PubMed Central

1 June 2018

Michael Andreeff

3

object named as

Michael Andreeff

1 reference

Europe PubMed Central

1 June 2018

Michael J. Keating

6

object named as

Michael Keating

1 reference

Europe PubMed Central

1 June 2018

Apostolia Maria Tsimberidou

1

object named as

Apostolia-Maria Tsimberidou

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

8

object named as

Elihu Estey

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

Maribel Tirado-Gomez

2

object named as

Maribel Tirado-Gomez

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

Gabriel Lopez-Berestein

7

object named as

Gabriel Lopez-Berestein

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

publication date

1 June 2006

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

Leukemia & Lymphoma

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

47

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

1062-1068

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Acute promyelocytic leukemia: evolving therapeutic strategies

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Therapy-related acute myeloid leukaemia after successful therapy for acute promyelocytic leukaemia with t(15;17): a report of two cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Long-term follow-up confirms the benefit of all-trans retinoic acid in acute promyelocytic leukemia. European APL group

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

All-trans-retinoic acid in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Established practice in the treatment of patients with acute promyleocytic leukemia and the introduction of arsenic trioxide as a novel therapy

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190500463932

21 January 2018

Identifiers

10.1080/10428190500463932

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/16840198

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54592312&oldid=1858463922"